Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
The Journal of Biological Chemistry|November 10, 1977
Complexing Rauscher leukemia virus reverse transcriptase with human plasma ribonuclease from Hodgkin's disease patientsA K Bandyopadhyay, C C Levy, M R MardineyJournal of the National Cancer Institute|November 11, 1975
The dependence of successful immunotherapy on adequate tumor burden as shown by the treatment of AKR leukemia with poly A-poly UW J Pendergrast, W P Drake, M R MardineyBiomedicine / [Publiee Pour L'A.A.I.C.I.G.]|January 1, 1978
Alteration of cellular ribonucleases associated with murine oncogenic virus infectionW P Drake, L M Frazier, D Sidle, et al.Cancer Research|March 11, 1976
The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR miceW P Drake, W J Pendergrast, R E Kramer, et al.Cancer Research|February 11, 1975
Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing miceW P Drake, L P Kopyta, C C Levy, et al.Cancer Research|October 1, 1976
Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcomaJ L Lichtenfeld, P H Wiernik, M R Mardiney, et al.The American Journal of Medicine|January 1, 1977
Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's diseaseJ C Ruckdeschel, S C Schimpff, A C Smyth, et al.Cancer Research|November 11, 1975
Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapyW P Drake, W J Pendergrast, R E Kramer, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 11, 1975
The kinetics of the interaction of heterologous anti-tumor serum and heterologous complement in non-tumor bearing miceW P Drake, G C Roberts, W J Pendergrast, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1976
In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced deathW P Drake, D R Pokorney, L P Kopyta, et al.Pageof 4